Figures & data
Table 1 Patient Demographics and Baseline Characteristics
Table 2 Association Between Patient Demographics and Baseline Characteristics and the Achievement of a CII at Week 4
Figure 1 Proportion of patients achieving a CII at Weeks 12 and 24 stratified by the achievement of a CII at Week 4.
![Figure 1 Proportion of patients achieving a CII at Weeks 12 and 24 stratified by the achievement of a CII at Week 4.](/cms/asset/ad0ca690-8ed6-40fe-8eb4-ec98e3cd3132/dcop_a_12163810_f0001_c.jpg)
Table 3 Ordered OR of GADS Improvement on the 7-Point Likert Scale at Week 4
Table 4 Combinations of PRO Responses at Week 4 by Treatment
Figure 2 Proportion of patients with a Clinically Important Deterioration (CID)a after Day 30 by: (A) achievement of a CII at Week 4; (B) the number of PRO responses at Week 4; (C) Kaplan–Meier curve of time to first CID in patients by achievement of CII at Week 4.
![Figure 2 Proportion of patients with a Clinically Important Deterioration (CID)a after Day 30 by: (A) achievement of a CII at Week 4; (B) the number of PRO responses at Week 4; (C) Kaplan–Meier curve of time to first CID in patients by achievement of CII at Week 4.](/cms/asset/81f6b543-96ff-4104-9714-3c4067cc4afa/dcop_a_12163810_f0002_c.jpg)
Table 5 Proportion of Patients Who Maintained Their Week 4 CII Status at Week 24
Figure 3 Proportion of patients achieving CII (reaching MCID in at least two PROs) at Weeks 4, 12 and 24a.
![Figure 3 Proportion of patients achieving CII (reaching MCID in at least two PROs) at Weeks 4, 12 and 24a.](/cms/asset/087e1748-b460-4f90-9f01-a40ea1f63a1b/dcop_a_12163810_f0003_c.jpg)